Implementation
- Initial IV bolus is to be given at time of ifosfamide administration.
- PO: If second and third doses are given orally, administer 2 and 6 hours after IV dose.
- If PO mesna is vomited within 2 hr of administration, repeat dose or use IV mesna.
- Syringe Compatibility
- Y-Site Compatibility
- allopurinol
- amifostine
- aztreonam
- cefepime
- docetaxel
- doxorubicin liposome
- etoposide phosphate
- filgrastim
- fludarabine
- gemcitabine
- granisetron
- linezolid
- melphalan
- methotrexate
- ondansetron
- oxaliplatin
- paclitaxel
- pemetrexed
- piperacillin/tazobactam
- sargramostim
- sodium bicarbonate
- teniposide
- thiotepa
- vinorelbine
- Y-Site Incompatibility
- amphotericin B cholesteryl complex
- lansoprazole
- Additive Compatibility
- Additive Incompatibility
- Rate: Administer over 15–30 min or as a continuous infusion.
- Syringe Compatibility
- Y-Site Compatibility
- allopurinol
- amifostine
- aztreonam
- cefepime
- docetaxel
- doxorubicin liposome
- etoposide phosphate
- filgrastim
- fludarabine
- gemcitabine
- granisetron
- linezolid
- melphalan
- methotrexate
- ondansetron
- oxaliplatin
- paclitaxel
- pemetrexed
- piperacillin/tazobactam
- sargramostim
- sodium bicarbonate
- teniposide
- thiotepa
- vinorelbine
- Y-Site Incompatibility
- amphotericin B cholesteryl complex
- lansoprazole
- Additive Compatibility
- Additive Incompatibility
mesna has been found in Davis's Drug Guide
If you are a registered user, please login below.
If not, learn more about gaining full access.
- Login
- Try and Buy
- Nursing Central puts five fully integrated references at your fingertips on mobile devices and the web. See how Nursing Central works by clicking the sample entries below or purchase a subscription for the web and your mobile device.
View these free topics online now.
![[Display All Sections]](images/m/display_all_btn.gif)
![[Top]](images/m/top.gif)
